Life Sciences

We provide innovation consulting services to the life sciences industry in the medical device, pharmaceutical and biotechnology segments.

Our team understands the industry's most critical challenges, including:

Maintaining regulatory compliance and efficiencies despite increasing requirements and FDA/international approval times

Battling pricing pressures driven by the Affordable Care Act and an ever-changing reimbursement climate

Accelerating launches of new and existing products in emerging global markets such as Asia Pacific, China and India

Leveraging mobile technologies and today’s interconnected environment to advance remote patient monitoring and self-diagnosis

We work with life sciences organizations to develop the strategies, organizational structure and capabilities they need to deliver commercially successful drugs, devices, products and services that meet today’s evolving healthcare needs.

Industry Segments

  • Biotechnology
  • Medical Device
  • Pharmaceuticals

Thoughtware

View more Viewpoints on Innovation

Medical Device Industry Playbook

The challenging macroeconomic business and regulatory climate is wreaking havoc on the medical device industry. Despite the challenges, manufacturers must design and implement effective, profitable innovation engines to capitalize on market…
Read More

Driving Innovation in BioPharma: From Discovery to Delivery with Product Lifecycle Management

Innovation in the biopharma industry is not going to get any easier, or any less complex. Adopting an entire lifecycle perspective to innovation will benefit the measures that matter the most – truly innovative products that generate real health…
Read More

UDI Impact on Medical Device Labeling: Lifting the Lid on Pandora’s Box

The FDA’s UDI ruling is more complicated than just a labeling change; it's multi-faceted and interconnected. Here are our tips for addressing UDI while continuing to innovate.
Read More

Beyond Compliance: Medical Device Product Development

Kalypso has spent the last several years exploring how leading medical device companies - from startups to multibillion dollar enterprises - are balancing new product development with compliance requirements. Finding the right balance between what…
Read More

Contacts

Request More Information

Chris Kay

Chris Kay

Life Sciences

Noel Sobelman

Noel Sobelman

Life Sciences

Scott Gibbard

Scott Gibbard

Pharmaceuticals & Biotechnology

Mick Broekhof

Mick Broekhof

Life Sciences Europe